A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Methyl nonanoate
Tesmilifene
The metabolism of Elexacaftor can be increased when combined with Tesmilifene.
Methyl nonanoate
Metamizole
The metabolism of Elexacaftor can be increased when combined with Metamizole.
Methyl nonanoate
Esketamine
The metabolism of Elexacaftor can be increased when combined with Esketamine.
Methyl nonanoate
Lesinurad
The metabolism of Elexacaftor can be increased when combined with Lesinurad.
Methyl nonanoate
Sarilumab
The metabolism of Elexacaftor can be increased when combined with Sarilumab.
Methyl nonanoate
Eslicarbazepine acetate
The metabolism of Elexacaftor can be increased when combined with Eslicarbazepine acetate.
Methyl nonanoate
Glycerol phenylbutyrate
The metabolism of Elexacaftor can be increased when combined with Glycerol phenylbutyrate.
Methyl nonanoate
Armodafinil
The metabolism of Elexacaftor can be increased when combined with Armodafinil.
Methyl nonanoate
Rufinamide
The metabolism of Elexacaftor can be increased when combined with Rufinamide.
Methyl nonanoate
Oritavancin
The metabolism of Elexacaftor can be increased when combined with Oritavancin.
Methyl nonanoate
Metreleptin
The metabolism of Elexacaftor can be increased when combined with Metreleptin.
Methyl nonanoate
Belantamab mafodotin
The excretion of Belantamab mafodotin can be decreased when combined with Elexacaftor.
Methyl nonanoate
Atrasentan
The excretion of Atrasentan can be decreased when combined with Elexacaftor.
Methyl nonanoate
Echinacea
The metabolism of Elexacaftor can be increased when combined with Echinacea.
Methyl nonanoate
Avasimibe
The metabolism of Elexacaftor can be increased when combined with Avasimibe.
SC-74020
Satralizumab
The serum concentration of Ubrogepant can be decreased when it is combined with Satralizumab.
SC-74020
Abametapir
The serum concentration of Ubrogepant can be increased when it is combined with Abametapir.
SC-74020
Dexniguldipine
The serum concentration of Ubrogepant can be increased when it is combined with Dexniguldipine.
SC-74020
Brefeldin A
The serum concentration of Ubrogepant can be increased when it is combined with Brefeldin A.
SC-74020
Pralsetinib
The serum concentration of Ubrogepant can be increased when it is combined with Pralsetinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3